A method for preventing radiation-induced ototoxicity in an individual in need thereof comprising intratympanic administration of a pharmaceutical composition comprising a therapeutic agent selected from a JNK inhibitor, TRPV modulator, an MET channel inhibitor, and an otoprotectant to the individual in need thereof, wherein the pharmaceutical composition is administered prior to onset of radiation therapy, and wherein the composition provides sustained release of the therapeutic agent into the ear for a period of at least 5 days after a single administration
Glucose Fluctuations: Because the peptide significantly enhances glucose uptake in skeletal muscle, it can cause rapid shifts in blood sugar levels
More severe injuries may require the full eight week protocol or extended maintenance dosing
This is the route used by InjectCo and other reputable medical aesthetics providers
Curr Drug Discov Technol
Today, Quicksilver Scientific offers science-backed, high-bioavailability supplements and synergistic formulas, along with valuable education for optimal health and wellness